Palisade Bio PALI
Palisade BIO, Inc. · Nasdaq · Biological Products, (No Diagnostic Substances)
$1.19-0.83%close on Oct. 28, 2026 · volume 15.1M · Yahoo Finance
Price, last 47 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| Oct. 2, 2026 | Donald Allen Williams director | Bought | 10,000 | $1.46 | $14,600 |
| Oct. 1, 2026 | Donald Allen Williams director | Bought | 10,000 | $1.42 | $14,200 |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.
Recent SEC filings
All 10 →Results of operations and financial condition · Financial statements and exhibits